NCT00579085View on ClinicalTrials.gov

Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

November 30, 2009

Conditions
Complex Regional Pain Syndrome
Interventions
DRUG

Ketamine

IV Ketamine .35mg/kg times ten days.

OTHER

IV NSS

Placebo inactive ingredients

OTHER

Normal Saline

"INFUSION PLAN:~All patients will be infused intravenously with 100 ml of normal saline for four hours (25 ml/hr) daily for 10 days.Both patient arms will receive 2mg of Versed x two doses IV. They will also receive Clonidine (0.1 mg, po)"

Trial Locations (1)

19107

Drexel University College of Medicine Department of Neurology, Philadelphia

All Listed Sponsors
lead

Drexel University College of Medicine

OTHER

NCT00579085 - Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS | Biotech Hunter | Biotech Hunter